+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

THU0391Axial Disease in Psoriatic Arthritis () Study: Serum-Soluble Bone-Turnover Biomarkers of Psoriatic Arthritis Phenotypes



THU0391Axial Disease in Psoriatic Arthritis () Study: Serum-Soluble Bone-Turnover Biomarkers of Psoriatic Arthritis Phenotypes



Annals of the Rheumatic Diseases 75(Suppl 2): 329.2-330




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 064924394

Download citation: RISBibTeXText

DOI: 10.1136/annrheumdis-2016-eular.2761


Related references

Serum soluble bone turnover biomarkers in psoriatic arthritis and psoriatic spondyloarthropathy. Journal of Rheumatology 42(1): 21-30, 2015

Serum bone-turnover biomarkers are associated with the occurrence of peripheral and axial arthritis in psoriatic disease: a prospective cross-sectional comparative study. Arthritis Research and Therapy 19(1): 210, 2017

Differentiating Psoriatic Arthritis From Psoriasis Without Psoriatic Arthritis Using Novel Serum Biomarkers. Arthritis Care and Research 70(3): 454-461, 2018

Rapidly progressive destructive arthritis in psoriatic arthritis sine psoriasis: do bone resorption marker levels predict outcome of bone destruction in psoriatic arthritis?. Modern Rheumatology 21(1): 106-108, 2011

SAT0403Further Analysis of Psoriatic Arthritis Disease Activity Score (PASDAS) and Composite Psoriatic Disease Activity Index (CPDAI) Using Data from A Placebo-Controlled TRIAL of Certolizumab Pegol in Psoriatic Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 740.1-740, 2014

Serum osteocalcin as an index of bone turnover in active rheumatoid arthritis and in active psoriatic arthritis. Clinical Rheumatology 8(4): 494-498, 1989

Soluble biomarkers differentiate patients with psoriatic arthritis from those with psoriasis without arthritis. Rheumatology 49(7): 1399-1405, 2010

AB0930DAREA/DAPSA (disease activity score for reactive arthritis/disease activity index for psoriatic arthritis) and related variables in patients with psoriatic arthritis (PSA):. Annals of the Rheumatic Diseases 71(Suppl 3): 691.18-691, 2013

Patient global assessment in psoriatic arthritis - what does it mean? An analysis of 223 patients from the Psoriatic arthritis impact of disease (PsAID) study. Joint Bone Spine 83(3): 335-340, 2016

Serum kallikrein-8 correlates with skin activity, but not psoriatic arthritis, in patients with psoriatic disease. Clinical Chemistry and Laboratory Medicine 51(2): 317-325, 2013

Development of a disease activity and responder index for psoriatic arthritis--report of the Psoriatic Arthritis Module at OMERACT 11. Journal of Rheumatology 41(4): 782-791, 2014

Psoriatic Arthritis and Burden of Disease: Patient Perspectives from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey. Rheumatology and Therapy 3(1): 91, 2016

Clinical Characteristics, Disease Activity, and Patient-Reported Outcomes in Psoriatic Arthritis Patients With Dactylitis or Enthesitis: Results From the Corrona Psoriatic Arthritis/Spondyloarthritis Registry. Arthritis Care and Research 69(11): 1692-1699, 2017

FRI0469Measuring Outcome in Psoriatic Arthritis (MOPSA), A New Web-Based Tool for Assessment of Psoriatic Arthritis Showing Initiation of Treatment Change in Patients Achieving Minimal Disease Activity. Annals of the Rheumatic Diseases 75(Suppl 2): 607.2-607, 2016

Clinical and ultrasonographic predictors for achieving minimal disease activity in patients with psoriatic arthritis: the UPSTREAM (Ultrasound in PSoriatic arthritis TREAtMent) prospective observational study protocol. Bmj Open 8(7): E021942, 2018